Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant

This review highlights recent advances in developing full synthetic carbohydrate antigen based vaccines, with an emphasis on the structure-activity relationships that provide a primary basis for future vaccine design and immunotherapy developing.